Approximately 5–10% of all of breast and ovarian cancer cases reflect inherited genetic defects primarily in two well-known high-penetrance breast and ovarian cancer genes, BRCA1 (breast cancer 1, early onset) and BRCA2 (breast cancer 2, early onset) [2–4]. This evidence concerns the gene BRCA1 and ovarian cancer.